250 related articles for article (PubMed ID: 2681638)
1. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.
Hohlfeld P; Daffos F; Thulliez P; Aufrant C; Couvreur J; MacAleese J; Descombey D; Forestier F
J Pediatr; 1989 Nov; 115(5 Pt 1):765-9. PubMed ID: 2681638
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of congenital toxoplasmosis].
Russo M; Galanti B
Clin Ter; 1990 Sep; 134(6):383-92. PubMed ID: 2149535
[TBL] [Abstract][Full Text] [Related]
3. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
Bessières MH; Berrebi A; Rolland M; Bloom MC; Roques C; Cassaing S; Courjault C; Séguéla JP
Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):37-45. PubMed ID: 11134824
[TBL] [Abstract][Full Text] [Related]
4. [Postnatal follow-up of infants born to mothers with certain Toxoplasma gondii infection: evaluation of prenatal management].
Di Carlo P; Mazzola A; Romano A; Schimmenti MG; Colicchia P; Bellipanni P; Titone L
Infez Med; 2005 Jun; 13(2):72-8. PubMed ID: 16220026
[TBL] [Abstract][Full Text] [Related]
5. Treatment of congenital toxoplasmosis during pregnancy.
Wilson CB
J Pediatr; 1990 Jun; 116(6):1003-5. PubMed ID: 2348287
[No Abstract] [Full Text] [Related]
6. [Toxoplasma infections in early pregnancy: consequences and management].
Wallon M; Gaucherand P; Al Kurdi M; Peyron F
J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):478-84. PubMed ID: 12379832
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid.
Gratzl R; Hayde M; Kohlhauser C; Hermon M; Burda G; Strobl W; Pollak A
Eur J Clin Microbiol Infect Dis; 1998 Dec; 17(12):853-8. PubMed ID: 10052549
[TBL] [Abstract][Full Text] [Related]
8. [Management of congenital toxoplasmosis in France: current data].
Garcia-Méric P; Franck J; Dumon H; Piarroux R
Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
[TBL] [Abstract][Full Text] [Related]
9. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
Mandelbrot L; Kieffer F; Sitta R; Laurichesse-Delmas H; Winer N; Mesnard L; Berrebi A; Le Bouar G; Bory JP; Cordier AG; Ville Y; Perrotin F; Jouannic JM; Biquard F; d'Ercole C; Houfflin-Debarge V; Villena I; Thiébaut R;
Am J Obstet Gynecol; 2018 Oct; 219(4):386.e1-386.e9. PubMed ID: 29870736
[TBL] [Abstract][Full Text] [Related]
10. Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone.
Vergani P; Ghidini A; Ceruti P; Strobelt N; Spelta A; Zapparoli B; Rescaldani R
Am J Reprod Immunol; 1998 May; 39(5):335-40. PubMed ID: 9602252
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of children with congenital toxoplasmosis.
Berrébi A; Assouline C; Bessières MH; Lathière M; Cassaing S; Minville V; Ayoubi JM
Am J Obstet Gynecol; 2010 Dec; 203(6):552.e1-6. PubMed ID: 20633868
[TBL] [Abstract][Full Text] [Related]
12. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.
Daffos F; Forestier F; Capella-Pavlovsky M; Thulliez P; Aufrant C; Valenti D; Cox WL
N Engl J Med; 1988 Feb; 318(5):271-5. PubMed ID: 3336419
[TBL] [Abstract][Full Text] [Related]
13. [Monitoring and treatment of toxoplasmosis in the pregnant woman, fetus and newborn].
Garin JP; Mojon M; Piens MA; Chevalier-Nuttall I
Pediatrie; 1989; 44(9):705-12. PubMed ID: 2695891
[TBL] [Abstract][Full Text] [Related]
14. [The Spanish Society of Pediatric Infectious Diseases Guidelines for the diagnosis and treatment of congenital toxoplasmosis].
Baquero-Artigao F; del Castillo Martín F; Fuentes Corripio I; Goncé Mellgren A; Fortuny Guasch C; de la Calle Fernández-Miranda M; González-Tomé MI; Couceiro Gianzo JA; Neth O; Ramos Amador JT;
An Pediatr (Barc); 2013 Aug; 79(2):116.e1-116.e16. PubMed ID: 23352717
[TBL] [Abstract][Full Text] [Related]
15. [Toxoplasmosis in pregnancy: Practical Management].
Mandelbrot L; Kieffer F; Wallon M; Winer N; Massardier J; Picone O; Fuchs F; Benoist G; Garcia-Meric P; L'Ollivier C; Paris L; Piarroux R; Villena I; Peyron F
Gynecol Obstet Fertil Senol; 2021 Oct; 49(10):782-791. PubMed ID: 33677120
[TBL] [Abstract][Full Text] [Related]
16. Toxoplasmosis.
Poindexter HA
J Natl Med Assoc; 1973 Sep; 65(5):399-401 passim. PubMed ID: 4795539
[No Abstract] [Full Text] [Related]
17. [Toxoplasmosis].
Maeda T
Nihon Rinsho; 2003 Feb; 61 Suppl 2():603-7. PubMed ID: 12722288
[No Abstract] [Full Text] [Related]
18. Congenital toxoplasmosis: therapeutic strategies.
Foulon W
Arch Pediatr; 2003 Feb; 10 Suppl 1():10-1. PubMed ID: 12802954
[No Abstract] [Full Text] [Related]
19. Congenital toxoplasmosis and prenatal care state programs.
Avelino MM; Amaral WN; Rodrigues IM; Rassi AR; Gomes MB; Costa TL; Castro AM
BMC Infect Dis; 2014 Jan; 14():33. PubMed ID: 24438336
[TBL] [Abstract][Full Text] [Related]
20. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.
Foulon W; Villena I; Stray-Pedersen B; Decoster A; Lappalainen M; Pinon JM; Jenum PA; Hedman K; Naessens A
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):410-5. PubMed ID: 9988811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
